BioSpace News Archive

Biotech Beach

Regulus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Regulus Therapeutics Inc today announced that CEO Jay Hagan will be presenting at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023.

August 2, 2023
·
3 min read
Biotech Bay

Karius Test®, a Liquid Biopsy for Infectious Diseases, Incorporated into Diagnostics Recommendation in the 2023 Duke-ISCVID Criteria for Infective Endocarditis

Karius®, Inc. a world leader in liquid biopsy for infectious diseases, has announced the inaugural inclusion of the Karius Test® in the 2023 Duke-ISCVID Criteria for Infective Endocarditis by the International Society of Cardiovascular Infectious Diseases.

August 2, 2023
·
4 min read
Pharm Country

Rallybio to Present at the 2023 Wedbush PacGrow Healthcare Conference

Rallybio Corporation today announced that Steve Uden, M.D., Chief Executive Officer of Rallybio, will participate in a panel discussion, “When You’re One in a Million – Orphan Drug Reimbursement/Regulation,” at the 2023 Wedbush PacGrow Healthcare Conference on August 9, 2023.

August 2, 2023
·
1 min read
Business

Summit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its second quarter 2023 financial results and provide an operational update for the Company on Wednesday, August 9, 2023, before the market opens.

August 2, 2023
·
5 min read
Business

ChromaDex to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, August 9, 2023 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended on June 30, 2023.

August 2, 2023
·
1 min read
Business

Minerva Surgical Reports Second Quarter 2023 Financial Results

Minerva Surgical, Inc. reported second quarter financial results for the period ended June 30, 2023.

August 2, 2023
·
10 min read
Business

TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023

TRACON Pharmaceuticals, Inc. (Nasdaq: TCON) announced today that it will report its second quarter 2023 financial and operating results after the close of U.S. financial markets on Monday, August 14, 2023.

August 2, 2023
·
2 min read
BioCapital

KALA BIO to Participate in Upcoming Investor Conferences in August 2023

KALA BIO, Inc. announced that management will participate in the following investor conferences in August 2023:

August 2, 2023
·
2 min read
Biotech Beach

Singular Genomics Announces Participation in the UBS MedTech, Tools and Genomics Summit

Singular Genomics Systems, Inc. announced plans to participate in the UBS MedTech, Tools and Genomics Summit in Dana Point, California.

August 2, 2023
·
1 min read
Business

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Inc. announced it will report its second quarter 2023 financial and operating results after the close of U.S. financial markets on Wednesday, August 9, 2023.

August 2, 2023
·
1 min read